Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kate Brain
Implementation of the NHS England Lung Cancer Screening Programme over 5 years
Abstract Lung cancer screening with low-dose computed tomography has been proven to reduce lung-cancer-specific and all-cause mortality. The UK launched the NHS England Targeted Lung Health Check Programme in 2019, which has now become the national Lung Cancer Screening Programme, with full coverage expected by 2030. Here we present the progress and outcomes of the program.
Hidden systems in primary care cancer detection: an embedded qualitative intervention development study
Method This qualitative study was guided by the COM-B model and the theoretical domains framework (TDF).
Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial
Introduction Low-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer-specific mortality in two large, randomised trials [1, 2], and implementation of screening is currently underway in many high- and middle-income countries [3]. Of those people responding to an invitation for lung cancer screening and subsequently eligible, between 30% and 50% are currently smoking [4, 5].
What should the role of primary care be in lung cancer screening?
Log in using your username and password Username * Enter your British Journal of General Practice username. Password * Enter the password that accompanies your username. Forgot your user name or password? Log in through your institution You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password. If your organization uses OpenAthens, you can log in using your OpenAthens username and password.
Multi-cancer early detection tests for cancer screening: a behavioural science perspective
Identifying circulating cell-free tumour DNA in blood offers the potential for multi-cancer early detection (MCED) tests. Several trials assessing the effect of MCED tests on early asymptomatic cancer detection are underway (eg, ISRCTN91431511 and NCT04213326 ). MCED tests differ substantially from existing cancer screening tests ( appendix p 1 ).
COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary
References 1. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020). CAS PubMed PubMed Central Article Google Scholar 2. World Health Organization (WHO). Global Cancer Statistics (WHO, 2018). 3. Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M. et al.
Development and psychometric testing of the self-regulatory questionnaire for lung cancer screening (SRQ-LCS)
Supplemental data for this article can be accessed here https://doi.org/10.1080/08870446.2021.1879806. Introduction Lung cancer is one of the leading causes of premature mortality in the UK and is highly socially graded (Iyen-Omofoman et al., 2011). A recent analysis estimated that 47% of lung cancer deaths in England would be avoided if all groups had the same risk as those in the highest deprivation decile (Lewer et al., 2020).
Use of Mobile Devices to Help Cancer Patients Meet Their Information Needs in Non-Inpatient Settings: Systematic Review
Citation Please cite as: Loading authors... Download: Published on 14.12.18 in Vol 6, No 12 (2018): December Preprints (earlier versions) of this paper are available at http://preprints.jmir.org/preprint/10026, first published Feb 02, 2018.
Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
The UK Lung Cancer Screening (UKLS) Pilot Trial is the first to assess the feasibility, cost-effectiveness and psychosocial impact of lung cancer screening using a single low-dose CT screen versus no screening in a UK high-risk population. 9 , 16 The current study builds upon previous UKLS reports by examining the behavioural effects of trial participation and modifying variables on smoking cessation at short-term and long-term follow-up.
Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
The UK Lung Cancer Screening (UKLS) pilot trial is the first to assess the feasibility, cost-effectiveness and psychosocial impact of lung cancer screening using a single low-dose CT screen versus no screening in a UK high-risk population. 9 16 The current study builds on previous UKLS reports by examining the behavioural effects of trial participation and modifying variables on smoking cessation at short-term and long-term follow-up.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kate
Contact Kate, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack